{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:09:08Z","timestamp":1788883748080,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40618-018-0903-3","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T15:49:55Z","timestamp":1527090595000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto\u2019s thyroiditis"],"prefix":"10.1007","volume":"42","author":[{"given":"R. M.","family":"Ruggeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cristani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Vicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Giovinazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Campenn\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"903_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1471-4906(01)02034-8","volume":"22","author":"E Dunn","year":"2001","unstructured":"Dunn E, Sims JE, Nicklin MJ, O\u2019Neill LA (2001) Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol 22:533\u2013536","journal-title":"Trends Immunol"},{"key":"903_CR2","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014\u20131022","journal-title":"Nat Immunol"},{"key":"903_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","volume":"22","author":"D Boraschi","year":"2011","unstructured":"Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, Italiani P, Nold MF, Nold-Petry CA, Bufler P, Dinarello CA (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127\u2013147","journal-title":"Eur Cytokine Netw"},{"key":"903_CR4","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1073\/pnas.1424626112","volume":"112","author":"S Li","year":"2015","unstructured":"Li S, Neff CP, Barber K, Hong J, Luo Y, Azam T, Palmer BE, Fujita M, Garlanda C, Mantovani A, Kim S, Dinarello CA (2015) Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8. Proc Natl Acad Sci USA 112:2497\u20132502","journal-title":"Proc Natl Acad Sci USA"},{"key":"903_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cyto.2014.11.025","volume":"72","author":"HM Chen","year":"2015","unstructured":"Chen HM, Fujita M (2015) IL-37: a new player in immune tolerance. Cytokine 72:113\u2013114","journal-title":"Cytokine"},{"key":"903_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.autrev.2015.08.006","volume":"12","author":"WD Xu","year":"2015","unstructured":"Xu WD, Zhao Y, Liu Y (2015) Insights into IL-37, the role in autoimmune diseases. Autoimmun Rev 12:1170\u20131175","journal-title":"Autoimmun Rev"},{"key":"903_CR7","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","volume":"11","author":"L Ye","year":"2015","unstructured":"Ye L, Jiang B, Deng J, Du J, Xiong W, Guan Y, Wen Z, Huang K, Huang Z (2015) IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J Immunol 11:5110\u20135119","journal-title":"J Immunol"},{"key":"903_CR8","doi-asserted-by":"crossref","first-page":"21775","DOI":"10.18632\/oncotarget.4887","volume":"6","author":"L Ye","year":"2015","unstructured":"Ye L, Huang Z (2015) IL-37 restrains autoimmune diseases. OncoTarget 6:21775\u201321776","journal-title":"OncoTarget"},{"key":"903_CR9","doi-asserted-by":"publisher","first-page":"11601","DOI":"10.1038\/s41598-017-11397-5","volume":"7","author":"L Ding","year":"2017","unstructured":"Ding L, Hong X, Sun B, Huang Q, Wang X, Liu X, Li L, Huang Z, Liu D (2017) IL-37 is associated with osteoarthritis disease activity and suppresses pro-inflammatory cytokines production in synovial cells. Sci Rep 7:11601","journal-title":"Sci Rep"},{"key":"903_CR10","doi-asserted-by":"publisher","first-page":"e95346","DOI":"10.1371\/journal.pone.0095346","volume":"9","author":"PW Zhao","year":"2014","unstructured":"Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF (2014) Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS ONE 9:e95346","journal-title":"PLoS ONE"},{"key":"903_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10875-012-9791-z","volume":"33","author":"L Song","year":"2013","unstructured":"Song L, Qiu F, Fan Y, Ding F, Liu H, Shu Q, Liu W, Li X (2013) Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 33:111\u2013117","journal-title":"J Clin Immunol"},{"key":"903_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1479-5876-12-69","volume":"12","author":"L Ye","year":"2014","unstructured":"Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu T, Chen B, Zhang J, Ding L, Du J, Huang Z (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69","journal-title":"J Transl Med"},{"key":"903_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cyto.2015.06.005","volume":"76","author":"L Xia","year":"2015","unstructured":"Xia L, Shen H, Lu J (2015) Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis attenuated the production of inflammatory cytokines. Cytokine 76:553\u2013557","journal-title":"Cytokine"},{"key":"903_CR14","doi-asserted-by":"publisher","first-page":"e107183","DOI":"10.1371\/journal.pone.0107183","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, Wang Z, Yu T, Chen B, Zhang J, Huang K, Huang Z (2014) Increased expression of IL-37 in patients with Graves\u2019 disease and its contribution to suppression of pro-inflammatory cytokines production in peripheral blood mononuclear cells. PLoS ONE 9:e107183","journal-title":"PLoS ONE"},{"key":"903_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR (2014) Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 13:391\u2013397","journal-title":"Autoimmun Rev"},{"key":"903_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s40619-018-0398-3","author":"E Fiore","year":"2018","unstructured":"Fiore E, Rago T, Ruggeri RM, Trimarchi F, Vitti P (2018) La tiroidite di Hashimoto: proposta di aggiornamento dei criteri diagnostici. L\u2019Endocrinologo. https:\/\/doi.org\/10.1007\/s40619-018-0398-3","journal-title":"L\u2019Endocrinologo"},{"key":"903_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/thy.2015.0592","volume":"4","author":"RM Ruggeri","year":"2016","unstructured":"Ruggeri RM, Vicchio TM, Cristani M, Certo R, Caccamo D, Alibrandi A, Giovinazzo S, Saija A, Campenn\u00ec A, Trimarchi F, Gangemi S (2016) Oxidative stress and advanced glycation end products in Hashimoto\u2019s thyroiditis. Thyroid 4:504\u2013511","journal-title":"Thyroid"},{"key":"903_CR18","first-page":"319","volume":"4","author":"A Aycicek","year":"2007","unstructured":"Aycicek A, Erel O (2007) Total oxidant\/antioxidant status in jaundiced newborns before and after phototherapy. J Pediatr (Rio J) 4:319\u2013322","journal-title":"J Pediatr (Rio J)"},{"key":"903_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44\u201384","journal-title":"Int J Biochem Cell Biol"},{"key":"903_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-011-9472-3","volume":"40","author":"M Aslan","year":"2011","unstructured":"Aslan M, Cosar N, Celik H, Aksoy N, Dulger AC, Begenik H, Soyoral YU, Kucukoglu ME, Selek S (2011) Evaluation of oxidative status in patients with hyperthyroidism. Endocrine 40:285\u2013289","journal-title":"Endocrine"},{"key":"903_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s12020-014-0399-3","volume":"48","author":"H Baser","year":"2014","unstructured":"Baser H, Can U, Baser S, Yerlikaya FH, Aslan U, Hidayetoglu BT (2014) Assessment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine 48:916\u2013923","journal-title":"Endocrine"},{"key":"903_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s40618-015-0278-7","volume":"11","author":"H Korkmaz","year":"2015","unstructured":"Korkmaz H, Tabur S, Ozkaya M, Oguz E, Aksoy N, Akarsu E (2015) Serum prolidase levels in Graves\u2019 disease without ophthalmopathy and its association with oxidative status. J Endocrinol Investig 11:1167\u20131173","journal-title":"J Endocrinol Investig"},{"key":"903_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s40618-016-0498-5","volume":"10","author":"Z Kucukayd\u0131n","year":"2016","unstructured":"Kucukayd\u0131n Z, Duran C, Basaran M, Camlica F, Erdem SS, Basaran A, Kutlu O, Burnik FS, Elmas H, Gonen MS (2016) Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome. J Endocrinol Investig 10:1139\u20131148","journal-title":"J Endocrinol Investig"},{"key":"903_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0809-5","author":"G Rotondo Dottore","year":"2017","unstructured":"Rotondo Dottore G, Ionni I, Menconi F, Casini G, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2017) Antioxidant effects of \u03b2-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves\u2019 orbitopathy (GO). J Endocrinol Investig. https:\/\/doi.org\/10.1007\/s40618-017-0809-5","journal-title":"J Endocrinol Investig"},{"key":"903_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0873-5","author":"A Samadi","year":"2018","unstructured":"Samadi A, Gurlek A, Sendur SN, Karahan S, Akbiyik F, Lay I (2018) Oxysterol species: reliable markers of oxidative stress in diabetes mellitus. J Endocrinol Investig. https:\/\/doi.org\/10.1007\/s40618-018-0873-5","journal-title":"J Endocrinol Investig"},{"key":"903_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40618-017-0624-z","volume":"40","author":"J Ye","year":"2017","unstructured":"Ye J, Zhong X, Du Y, Cai C, Pan T (2017) Role of levothyroxine and vitamin E supplementation in the treatment of oxidative stress-induced injury and apoptosis of myocardial cells in hypothyroid rats. J Endocrinol Investig 40:713\u2013719","journal-title":"J Endocrinol Investig"},{"key":"903_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/cei.12284","volume":"176","author":"B Wu","year":"2014","unstructured":"Wu B, Meng K, Ji Q, Cheng M, Yu K, Zhao X, Tony H, Liu Y, Zhou Y, Chang C, Zhong Y, Zhu Z, Zhang W, Mao X, Zeng Q (2014) Interleukin-37 ameliorates myocardial ischaemia\/reperfusion injury in mice. Clin Exp Immunol 176:438\u2013451","journal-title":"Clin Exp Immunol"},{"key":"903_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/exd.12103","volume":"22","author":"NC Laddha","year":"2013","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachandran AV, Dalai S, Begum R (2013) Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol 22:245\u2013250","journal-title":"Exp Dermatol"},{"key":"903_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ni1112","volume":"10","author":"A Iwasaki","year":"2004","unstructured":"Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 10:987\u2013995","journal-title":"Nat Immunol"},{"key":"903_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1189\/jlb.0304127","volume":"76","author":"MF Tsan","year":"2004","unstructured":"Tsan MF, Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76:514\u2013519","journal-title":"J Leukoc Biol"},{"key":"903_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fimmu.2016.00578","volume":"7","author":"S Peng","year":"2016","unstructured":"Peng S, Li C, Wang X, Liu X, Han C, Jin T, Liu S, Zhang X, Zhang H, He X, Xie X, Yu X, Wang C, Shan L, Fan C, Shan Z, Teng W (2016) Increased Toll-like receptors activity and TLR ligands in patients with autoimmune thyroid diseases. Front Immunol 7:578","journal-title":"Front Immunol"},{"key":"903_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-0035-1548832","volume":"47","author":"RA Ajjan","year":"2015","unstructured":"Ajjan RA, Weetman AP (2015) The pathogenesis of Hashimoto\u2019s thyroiditis: further developments in our understanding. Horm Metab Res 47:702\u2013710","journal-title":"Horm Metab Res"},{"key":"903_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.EJ13-0484","volume":"4","author":"RM Ruggeri","year":"2014","unstructured":"Ruggeri RM, Saitta S, Cristani M, Giovinazzo S, Tigano V, Trimarchi F, Benvenga S, Gangemi S (2014) Serum interleukin-23 (IL-23) is increased in Hashimoto\u2019s thyroiditis. Endocr J 4:359\u2013363","journal-title":"Endocr J"},{"key":"903_CR34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.14310\/horm.2002.1483","volume":"3","author":"RM Ruggeri","year":"2014","unstructured":"Ruggeri RM, Minciullo P, Saitta S, Giovinazzo S, Certo R, Campenn\u00ec A, Trimarchi F, Gangemi S, Benvenga S (2014) Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto\u2019s thyroiditis compared to non-autoimmune thyroid disease and healthy controls. Hormones (Athens) 3:338\u2013344","journal-title":"Hormones (Athens)"},{"key":"903_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12020-015-0759-7","volume":"52","author":"R Gonz\u00e1lez-Amaro","year":"2016","unstructured":"Gonz\u00e1lez-Amaro R, Marazuela M (2016) T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine 52:30\u201338","journal-title":"Endocrine"},{"key":"903_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40618-013-0013-1","volume":"1","author":"L Shi","year":"2014","unstructured":"Shi L, Bi M, Yang R, Zhou J, Zhao S, Fan C, Shan Z, Li Y, Teng W (2014) Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice. J Endocrinol Investig 1:43\u201350","journal-title":"J Endocrinol Investig"},{"key":"903_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.clim.2017.04.012","volume":"184","author":"MG Santaguida","year":"2017","unstructured":"Santaguida MG, Gatto I, Mangino G, Virili C, Stramazzo I, Fallahi P, Antonelli A, Segni M, Romeo G, Centanni M (2017) BREG cells in Hashimoto\u2019s thyroiditis isolated or associated to further organ-specific autoimmune diseases. Clin Immunol 184:42\u201347","journal-title":"Clin Immunol"},{"key":"903_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biocel.2017.08.002","volume":"90","author":"S Yu","year":"2017","unstructured":"Yu S, Qi Y, Wang H, Jiang J, Sun L, Zhou Q (2017) Dysfunction of CD24+ CD38+ B cells in patients with Hashimoto\u2019s thyroiditis is associated with a lack of interleukin 10. Int J Biochem Cell Biol 90:114\u2013120","journal-title":"Int J Biochem Cell Biol"},{"key":"903_CR39","doi-asserted-by":"publisher","first-page":"16711","DOI":"10.1073\/pnas.1111982108","volume":"108","author":"EN McNamee","year":"2011","unstructured":"McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J (2011) Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 108:16711\u201316716","journal-title":"Proc Natl Acad Sci USA"},{"key":"903_CR40","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.4049\/jimmunol.1300047","volume":"192","author":"X Teng","year":"2014","unstructured":"Teng X, Hu Z, Wei X, Wang Z, Guan T, Liu N, Liu X, Ye N, Deng G, Luo C, Huang N, Sun C, Xu M, Zhou X, Deng H, Edwards CK III, Chen X, Wang X, Cui K, Wei Y, Li J (2014) IL-37 ameliorates the inflammatory process in psoriasis by suppressing pro-inflammatory cytokine production. J Immunol 192:1815\u20131823","journal-title":"J Immunol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0903-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T18:25:33Z","timestamp":1751653533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0903-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["903"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0903-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no potential conflict of interest and the authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in comply with ethical standards which is in accordance with the 1964 Helsinki Declaration and its later amendments. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent from each subject and Ethics Committee approval was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}